Vaxcyte Inc Vaxcyte Inc witnessed a rebound after testing the uptrend line at 70.79, to close below the last peak 76, which is the level that needs to be violated, to shift the trend to an uptrend, which will trigger further rises near 78.39 - 82 - 84.80 - 87 - 88.55 - 90.20.
The stop-loss lies below 71.95.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.6 EUR
−448.14 M EUR
0.00 EUR
125.99 M
About Vaxcyte, Inc.
Sector
Industry
CEO
Grant E. Pickering
Website
Headquarters
San Carlos
Founded
2013
FIGI
BBG01TNXMRK1
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.
No news here
Looks like there's nothing to report right now
PcvxThis could get going. Nice vol on the gap up
Now if it can put in another contraction for a couple days. And then take out a solid pivot would give nic r/r with a tight stop
NLong

PCVX Technical Analysis 🧙Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from most common and deadly diseases.
If you understand the idea,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow
NLong

NLong

PCVX to target 42 dollar range!Hi! Taking a long PCVX at 39.60 with a target of 42.95. This could pull back as much as 3%, but who knows, so might want to wait for the entry, or not.
NLong

See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently Asked Questions
The current price of 1PCVX is 25.6 EUR — it hasn't changed in the past 24 hours. Watch VAXCYTE INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange VAXCYTE INC stocks are traded under the ticker 1PCVX.
1PCVX stock has fallen by −11.72% compared to the previous week, the month change is a −14.67% fall, over the last year VAXCYTE INC has showed a −12.33% decrease.
We've gathered analysts' opinions on VAXCYTE INC future price: according to them, 1PCVX price has a max estimate of 139.75 EUR and a min estimate of 42.87 EUR. Watch 1PCVX chart and read a more detailed VAXCYTE INC stock forecast: see what analysts think of VAXCYTE INC and suggest that you do with its stocks.
1PCVX reached its all-time high on Jul 17, 2025 with the price of 32.4 EUR, and its all-time low was 25.6 EUR and was reached on Aug 7, 2025. View more price dynamics on 1PCVX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1PCVX stock is 0.00% volatile and has beta coefficient of 1.66. Track VAXCYTE INC stock price on the chart and check out the list of the most volatile stocks — is VAXCYTE INC there?
Today VAXCYTE INC has the market capitalization of 3.34 B, it has decreased by −9.17% over the last week.
Yes, you can track VAXCYTE INC financials in yearly and quarterly reports right on TradingView.
VAXCYTE INC is going to release the next earnings report on Nov 10, 2025. Keep track of upcoming events with our Earnings Calendar.
1PCVX earnings for the last quarter are −1.04 EUR per share, whereas the estimation was −0.98 EUR resulting in a −5.17% surprise. The estimated earnings for the next quarter are −1.09 EUR per share. See more details about VAXCYTE INC earnings.
VAXCYTE INC revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
1PCVX net income for the last quarter is −141.40 M EUR, while the quarter before that showed −130.07 M EUR of net income which accounts for −8.71% change. Track more VAXCYTE INC financial stats to get the full picture.
No, 1PCVX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Aug 11, 2025, the company has 414 employees. See our rating of the largest employees — is VAXCYTE INC on this list?
Like other stocks, 1PCVX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VAXCYTE INC stock right from TradingView charts — choose your broker and connect to your account.